European Commission approves low-dose atropine eye drop Ryjunea, Santen announces - Optometry Times
  Jimmy Santen Obituary - St. Louis, MO - Dignity Memorial
  Santen receives marketing authorization application approval from NMPA of China for tafluprost/timolol maleate (Tapcom) in patients with open-angle glaucoma - Ophthalmology Times
  EC approves Santen’s Ryjunea to slow progression of paediatric myopia - PharmaTimes
  Is Santen Pharmaceutical Co., Ltd.'s (TSE:4536) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st
  Santen, Arctic Vision sign deal for ARVN001 to treat UME - Pharmaceutical Technology
  EC approves Santen’s Ryjunea to slow progression of pediatric myopia - The Pharma Letter
  Santen Pharmaceutical Announces Strategic Share Buyback Plan - TipRanks